Home/Filings/4/0001415889-24-021750
4//SEC Filing

DeVaul William 4

Accession 0001415889-24-021750

CIK 0001679363other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 7:01 PM ET

Size

30.8 KB

Accession

0001415889-24-021750

Insider Transaction Report

Form 4
Period: 2024-08-16
DeVaul William
General Counsel and Secretary
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-16103,8550 total
    Exercise: $4.32Exp: 2028-12-14Common Stock (103,855 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-1675,0000 total
    Exercise: $30.19Exp: 2031-01-14Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-1657,7920 total
    Exercise: $44.75Exp: 2032-01-13Common Stock (57,792 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-1615,5080 total
    Exercise: $15.00Exp: 2029-06-26Common Stock (15,508 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-1674,7000 total
    Exercise: $15.42Exp: 2030-02-17Common Stock (74,700 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-1669,6000 total
    Exercise: $27.79Exp: 2034-01-11Common Stock (69,600 underlying)
  • Disposition to Issuer

    Common Stock

    2024-08-1619,5870 total
  • Disposition to Issuer

    Restricted Stock Unit

    2024-08-1632,8500 total
    Common Stock (32,850 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2024-08-1644,4000 total
    Common Stock (44,400 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-1662,1600 total
    Exercise: $31.72Exp: 2033-01-12Common Stock (62,160 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2024-08-166,5000 total
    Common Stock (6,500 underlying)
Footnotes (13)
  • [F1]On July 7, 2024, Morphic Holding, Inc., a Delaware corporation (the "Issuer" or the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Eli Lilly and Company, an Indiana corporation (the "Parent"), and Rainier Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of the Parent ("Merger Sub"). Pursuant to the Merger Agreement, the Merger Sub merged with and into the Company (the "Merger") with the Company surviving the Merger as a wholly owned subsidiary of the Parent.
  • [F10]The RSUs vest as to 25% of the total shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, subject to the reporting person's provision of service to the Issuer on each vesting date.
  • [F11]Pursuant to the Merger Agreement, each RSU that was outstanding but not vested as of immediately prior to the Closing (the "Unvested RSU"), became immediately vested in full (the "Vested RSU"). Each Vested RSU was automatically cancelled and converted into the right to receive an amount in cash, without interest, less any applicable tax withholding, equal to the product obtained by multiplying (i) the Offer Price by (ii) the number of shares of Common Stock underlying such RSU.
  • [F12]The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025 and January 14, 2026, subject to the reporting person's provision of service to the Issuer on each vesting date.
  • [F13]The RSUs vest as to 25% of the total shares on each of January 12, 2025, January 12, 2026, January 12, 2027 and January 12, 2028, subject to the reporting person's provision of service to the Issuer on each vesting date.
  • [F2](Continued from Footnote 1) Upon the closing (the "Closing") of the Merger on August 16, 2024, each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), was either (x) purchased by Purchaser for $57.00 per share (the "Offer Price"), without interest, less any applicable tax withholding or (y) automatically converted into the right to receive the Offer Price in cash without interest, less any applicable tax withholding.
  • [F3]The Company Stock Option ("Option") is fully vested.
  • [F4]Pursuant to the Merger Agreement, each Option that was outstanding but not vested as of immediately prior to the Closing (the "Unvested Option") became fully vested and exercisable (the "Vested Option"). Each Vested Option was automatically cancelled and converted into the right to receive an amount in cash without interest, less any applicable tax withholding, equal to the product obtained by multiplying (i) the excess, if any, of the Offer Price over the exercise price per share of Common Stock underlying such Option by (ii) the number of shares of Common Stock underlying such Option. If the exercise price per share of Common Stock of the underlying Option was equal to or greater than the Offer Price, such Option was cancelled without any cash payment or other consideration being made in respect thereof.
  • [F5]The Option vests as to 2.0833% of the total shares monthly, beginning February 15, 2021, with 100% of the total shares vested and exercisable on January 15, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.
  • [F6]The Option vests as to 2.0833% of the total shares monthly, beginning February 14, 2022, with 100% of the total shares vested and exercisable on January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
  • [F7]The Option vests as to 2.0833% of the total shares monthly, beginning February 13, 2023, with 100% of the total shares vested and exercisable on January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
  • [F8]The Option vests as to 2.0833% of the total shares monthly, beginning February 12, 2024, with 100% of the total shares vested and exercisable on January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date.
  • [F9]Each Company Restricted Stock Unit ("RSUs") represents a contingent right to receive one (1) share of Common Stock upon settlement for no consideration.

Issuer

Morphic Holding, Inc.

CIK 0001679363

Entity typeother

Related Parties

1
  • filerCIK 0001780270

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 7:01 PM ET
Size
30.8 KB